Table Of Contents
1. Introduction
1.1 Market Definition & Scope
1.2 Research Assumptions & Abbreviations
1.3 Research Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2021–2032
2.3 Market Size & Forecast, By Segmentation, 2021–2032
2.3.1 Market Size By Route of Administration
2.3.2 Market Size By Indication
2.3.3 Market Size By Type
2.3.4 Market Size By Age
2.3.5 Market Size By Distribution Channel
2.4 Market Share & Bps Analysis By Region, 2024
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1 Raw Material Suppliers
3.4.2 Manufacturers
3.4.3 Distributors/Suppliers
3.4.4 Customers/End-Users
3.5 Industry Life Cycle Assessment
3.6 Parent Market Overview
3.7 Market Risk Assessment
4. Statistical Insights & Trends Reporting
4.1 Vaccination Coverage & Uptake Rates
4.1.1 Global immunization coverage rates (%) by age group and vaccine type
4.1.2 Percentage of population covered under national immunization programs
4.1.3 Urban vs. rural vaccination uptake trends
4.2 Research & Development Statistics
4.2.1 Number of vaccine candidates in clinical trials by phase
4.2.2 Average R&D investment per vaccine (USD million)
4.2.3 Approval success rate (%) of vaccines from clinical trial to market
4.3 Distribution & Accessibility Metrics
4.3.1 Percentage of vaccines distributed via public vs. private healthcare channels
4.3.2 Cold chain logistics adoption rate (%) for vaccine delivery
4.3.3 Average time-to-market for vaccines in developed vs. emerging economies
4.4 Public Health & Impact Analysis
4.4.1 Reduction in disease incidence (%) due to widespread vaccination
4.4.2 Mortality reduction statistics linked to specific vaccines (e.g., measles, HPV, COVID-19)
4.4.3 Percentage of global healthcare expenditure allocated to vaccination programs
5. Vaccine Market Segmental Analysis & Forecast, By Route of Administration, 2021 – 2032, Value (USD Billion)
5.1 Introduction
5.2 Oral
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2021 – 2032
5.3 Parenteral
5.4 Nasal
6. Vaccine Market Segmental Analysis & Forecast, By Indication, 2021 – 2032, Value (USD Billion)
6.1 Introduction
6.2 Viral Diseases
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2021 – 2032
6.3 Bacterial Vaccines
6.4 Cancer Vaccines
6.5 Allergy Vaccines
7. Vaccine Market Segmental Analysis & Forecast, By Type, 2021 – 2032, Value (USD Billion)
7.1 Introduction
7.2 Subunit Vaccines
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2021 – 2032
7.3 Inactivated
7.4 Live attenuated
7.5 mRNA vaccines
7.6 Viral vector vaccines
8. Vaccine Market Segmental Analysis & Forecast, By Age, 2021 – 2032, Value (USD Billion)
8.1 Introduction
8.2 Pediatric
8.2.1 Key Trends
8.2.2 Market Size & Forecast, 2021 – 2032
8.3 Adult
9. Vaccine Market Segmental Analysis & Forecast, By Distribution Channel, 2021 – 2032, Value (USD Billion)
9.1 Introduction
9.2 Hospital & Retail Pharmacies
9.2.1 Key Trends
9.2.2 Market Size & Forecast, 2021 – 2032
9.3 Government Suppliers
9.4 Others
10. Vaccine Market Segmental Analysis & Forecast By Region, 2021 – 2032, Value (USD Billion)
10.1 Introduction
10.2 North America
10.2.1 Key Trends
10.2.2 Vaccine Market Size & Forecast, By Route of Administration, 2021 – 2032
10.2.3 Vaccine Market Size & Forecast, By Indication, 2021 – 2032
10.2.4 Vaccine Market Size & Forecast, By Type, 2021 – 2032
10.2.5 Vaccine Market Size & Forecast, By Age, 2021 – 2032
10.2.6 Vaccine Market Size & Forecast, By Distribution Channel, 2021 – 2032
10.2.7 Vaccine Market Size & Forecast, By Country, 2021 – 2032
10.2.7.1 USA
10.2.7.2 Canada
10.3 Europe
10.3.1 Key Trends
10.3.2 Vaccine Market Size & Forecast, By Route of Administration, 2021 – 2032
10.3.3 Vaccine Market Size & Forecast, By Indication, 2021 – 2032
10.3.4 Vaccine Market Size & Forecast, By Type, 2021 – 2032
10.3.5 Vaccine Market Size & Forecast, By Age, 2021 – 2032
10.3.6 Vaccine Market Size & Forecast, By Distribution Channel, 2021 – 2032
10.3.7 Vaccine Market Size & Forecast, By Country, 2021 – 2032
10.3.7.1 Germany
10.3.7.2 UK
10.3.7.3 France
10.3.7.4 Italy
10.3.7.5 Spain
10.3.7.6 Russia
10.3.7.7 Poland
10.3.7.8 Rest of Europe
10.4 Asia-Pacific
10.4.1 Key Trends
10.4.2 Vaccine Market Size & Forecast, By Route of Administration, 2021 – 2032
10.4.3 Vaccine Market Size & Forecast, By Indication, 2021 – 2032
10.4.4 Vaccine Market Size & Forecast, By Type, 2021 – 2032
10.4.5 Vaccine Market Size & Forecast, By Age, 2021 – 2032
10.4.6 Vaccine Market Size & Forecast, By Distribution Channel, 2021 – 2032
10.4.7 Vaccine Market Size & Forecast, By Country, 2021 – 2032
10.4.7.1 China
10.4.7.2 India
10.4.7.3 Japan
10.4.7.4 South Korea
10.4.7.5 Australia
10.4.7.6 ASEAN Countries
10.4.7.7 Rest of Asia-Pacific
10.5 Latin America
10.5.1 Key Trends
10.5.2 Vaccine Market Size & Forecast, By Route of Administration, 2021 – 2032
10.5.3 Vaccine Market Size & Forecast, By Indication, 2021 – 2032
10.5.4 Vaccine Market Size & Forecast, By Type, 2021 – 2032
10.5.5 Vaccine Market Size & Forecast, By Age, 2021 – 2032
10.5.6 Vaccine Market Size & Forecast, By Distribution Channel, 2021 – 2032
10.5.7 Vaccine Market Size & Forecast, By Country, 2021 – 2032
10.5.7.1 Brazil
10.5.7.2 Argentina
10.5.7.3 Mexico
10.5.7.4 Colombia
10.5.7.5 Rest of Latin America
10.6 Middle East & Africa
10.6.1 Key Trends
10.6.2 Vaccine Market Size & Forecast, By Route of Administration, 2021 – 2032
10.6.3 Vaccine Market Size & Forecast, By Indication, 2021 – 2032
10.6.4 Vaccine Market Size & Forecast, By Type, 2021 – 2032
10.6.5 Vaccine Market Size & Forecast, By Age, 2021 – 2032
10.6.6 Vaccine Market Size & Forecast, By Distribution Channel, 2021 – 2032
10.6.7 Vaccine Market Size & Forecast, By Country, 2021 – 2032
10.6.7.1 UAE
10.6.7.2 Saudi Arabia
10.6.7.3 Qatar
10.6.7.4 Egypt
10.6.7.5 South Africa
10.6.7.6 Rest of Middle East & Africa
11. Competitive Landscape
11.1 Key Players' Positioning
11.2 Competitive Developments
11.2.1 Key Strategies Adopted (%), By Key Players, 2024
11.2.2 Year-Wise Strategies & Development, 2021 – 2025
11.2.3 Number Of Strategies Adopted By Key Players, 2024
11.3 Market Share Analysis, 2024
11.4 Product/Service & Application Benchmarking
11.4.1 Product/Service Specifications & Features By Key Players
11.4.2 Product/Service Heatmap By Key Players
11.4.3 Application Heatmap By Key Players
11.5 Industry Start-Up & Innovation Landscape
11.6 Key Company Profiles
11.6.1 Serum Institute of India Pvt. Ltd.
11.6.1.1 Company Overview & Snapshot
11.6.1.2 Product/Service Portfolio
11.6.1.3 Key Company Financials
11.6.1.4 SWOT Analysis
11.6.2 Seqirus
11.6.3 Sanofi
11.6.4 GSK Plc.
11.6.5 Merck & Co., Inc.
11.6.6 Pfizer Inc.
11.6.7 Moderna Inc.
11.6.8 Sinovac
11.6.9 BioNTech SE
11.6.10 AstraZeneca
11.6.11 Novartis AG
11.6.12 Emergent BioSolutions, Inc.
11.6.13 Inovio Pharmaceuticals, Inc.
11.6.14 Bavarian Nordic
11.6.15 Mitsubishi Tanabe Pharma Corporation
11.6.16 Bavarian Nordic
11.6.17 CSL Limited
11.6.18 Johnson & Johnson
11.6.19 Bharat Biotech
11.6.20 Dynavax Technologies
12. Analyst Recommendations
12.1 SNS Insider Opportunity Map
12.2 Industry Low-Hanging Fruit Assessment
12.3 Market Entry & Growth Strategy
12.4 Analyst Viewpoint & Suggestions On Market Growth
13. Assumptions
14. Disclaimer
15. Appendix
15.1 List Of Tables
15.2 List Of Figure
